Annuncio • 16h
Advance ZincTek Limited Provides Unaudited Earnings Guidance for the Fiscal Year 2026 Advance ZincTek Limited provided unaudited earnings guidance for the fiscal year 2026. For the year, the company expects sales revenue to increase by 12.65%, from $11.638 million in the fiscal year 2025 to $13.111 million in in the fiscal year 2026. Board Change • Apr 29
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 3 highly experienced directors. No independent directors (3 non-independent directors). MD, Company Secretary & Executive Director Geoff Acton was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Apr 09
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 3 highly experienced directors. No independent directors (3 non-independent directors). MD, Company Secretary & Executive Director Geoff Acton was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Mar 12
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 3 highly experienced directors. No independent directors (3 non-independent directors). MD, Company Secretary & Executive Director Geoff Acton was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Recent Insider Transactions • Nov 30
Non-Executive Chairman recently bought AU$90k worth of stock On the 27th of November, Lev Mizikovsky bought around 75k shares on-market at roughly AU$1.19 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Lev has been a buyer over the last 12 months, purchasing a net total of AU$243k worth in shares. Valuation Update With 7 Day Price Move • Oct 23
Investor sentiment improves as stock rises 30% After last week's 30% share price gain to AU$1.24, the stock trades at a trailing P/E ratio of 62.5x. Average trailing P/E is 23x in the Chemicals industry globally. Total loss to shareholders of 41% over the past three years. Annuncio • Oct 18
Advance ZincTek Limited, Annual General Meeting, Nov 14, 2025 Advance ZincTek Limited, Annual General Meeting, Nov 14, 2025. Location: at aicd, level 9, riverside centre, 123 eagle st, brisbane city qld 4001 Australia Reported Earnings • Aug 31
Full year 2025 earnings released: EPS: AU$0.02 (vs AU$0.014 loss in FY 2024) Full year 2025 results: EPS: AU$0.02 (up from AU$0.014 loss in FY 2024). Revenue: AU$12.3m (up 24% from FY 2024). Net income: AU$1.24m (up AU$2.14m from FY 2024). Profit margin: 10% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 49 percentage points per year, which is a significant difference in performance. New Risk • Jul 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 58% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (AU$57.3m market cap, or US$37.8m). Reported Earnings • Feb 21
First half 2025 earnings released: EPS: AU$0.015 (vs AU$0.01 in 1H 2024) First half 2025 results: EPS: AU$0.015 (up from AU$0.01 in 1H 2024). Revenue: AU$6.25m (up 2.5% from 1H 2024). Net income: AU$954.0k (up 48% from 1H 2024). Profit margin: 15% (up from 11% in 1H 2024). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 38 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Nov 13
Non-Executive Chairman recently bought AU$61k worth of stock On the 11th of November, Lev Mizikovsky bought around 81k shares on-market at roughly AU$0.76 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth AU$78k. Lev has been a buyer over the last 12 months, purchasing a net total of AU$229k worth in shares. Recent Insider Transactions • Nov 05
Non-Executive Chairman recently bought AU$78k worth of stock On the 1st of November, Lev Mizikovsky bought around 102k shares on-market at roughly AU$0.76 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Lev has been a buyer over the last 12 months, purchasing a net total of AU$147k worth in shares. Annuncio • Sep 13
Advance ZincTek Limited, Annual General Meeting, Oct 14, 2024 Advance ZincTek Limited, Annual General Meeting, Oct 14, 2024. Location: morgans, level 29, riverside centre, 123 eagle st, brisbane city qld 4001, Australia Reported Earnings • Aug 31
Full year 2024 earnings released: AU$0.014 loss per share (vs AU$0.027 profit in FY 2023) Full year 2024 results: AU$0.014 loss per share (down from AU$0.027 profit in FY 2023). Revenue: AU$10.0m (down 31% from FY 2023). Net loss: AU$903.0k (down 154% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 41% per year, which means it is performing significantly worse than earnings. New Risk • Aug 20
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 42% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Profit margins are more than 30% lower than last year (7.8% net profit margin). Market cap is less than US$100m (AU$45.0m market cap, or US$30.2m). Annuncio • May 31
Advance Zinctek Limited Announces Board Changes Advance ZincTek Limited announced that one of its Non-executive Directors has resigned, Linda Barr (Chair of Audit Committee). The Board is in the process of defining skills required to replace Linda on the Board of AdvanceZincTek. In the meantime, Rade Dudurovic will assume the Chair of Audit Committee responsibilities. Rade has an extensive background in private equity with strong exposure to industrial and branded consumer manufacturing and distribution businesses particularly in the Asian region. He has qualifications in commerce and law and is a CPA as well as Senior Fellow of FINSIA. Annuncio • Feb 08
Mizikovsky Group completed the acquisition of 12.17% stake in Advance ZincTek Limited (ASX:ANO). Mizikovsky Group made an offer to acquire additional 48.42% stake in Advance ZincTek Limited (ASX:ANO) for AUD32 million on October 11, 2023. As part of the offer, Mizikovsky will acquire 11.24 million share of Advance ZincTek for AUD 0.97 per share. The Mizikovsky Group currently has a relevant interest in approximately 51.58% of the ANO shares on issue. As a part of acquisition, Mizikovsky Group’s aggregate shareholding in ANO will increase from approximately 51.58% to 70%. There is no minimum acceptance. Advisory Partners Pty Ltd acted as the Financial advisor and the fairness opinion provider and Sparke Helmore Lawyers acted as the legal advisor to Advance ZincTek.
Mizikovsky Group completed the acquisition of 12.17% stake in Advance ZincTek Limited (ASX:ANO) on February 6, 2024. Reported Earnings • Feb 07
First half 2024 earnings released: EPS: AU$0.01 (vs AU$0.021 in 1H 2023) First half 2024 results: EPS: AU$0.01 (down from AU$0.021 in 1H 2023). Revenue: AU$6.10m (down 18% from 1H 2023). Net income: AU$643.0k (down 49% from 1H 2023). Profit margin: 11% (down from 17% in 1H 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 39% per year, which means it is significantly lagging earnings. Board Change • Dec 04
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-executive Director Linda Barr was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. New Risk • Oct 10
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Dividend is not well covered by earnings and cash flows. Dividend per share is over 5x earnings per share. Dividend per share is over 6x cash flows per share. Earnings have declined by 31% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (11% net profit margin). Market cap is less than US$100m (AU$55.6m market cap, or US$35.6m). Annuncio • Sep 11
Advance ZincTek Limited, Annual General Meeting, Oct 10, 2023 Advance ZincTek Limited, Annual General Meeting, Oct 10, 2023, at 11:30 E. Australia Standard Time. Location: Australian Institute of Company Directors, Level 9, Riverside Centre 123 Eagle St, Brisbane City QLD 4001 Brisbane Australia Agenda: To receive and consider the Company's financial statements, the related Directors Report, Directors' Declaration and Independent Audit Report for the financial year ended 30 June 2023; to consider remuneration report; and to consider re-election of Lev Mizikovsky as a Director. Valuation Update With 7 Day Price Move • Sep 07
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to AU$1.02, the stock trades at a trailing P/E ratio of 38.3x. Average trailing P/E is 16x in the Chemicals industry in Australia. Total loss to shareholders of 68% over the past three years. Recent Insider Transactions • Sep 02
Non-Executive Chairman recently bought AU$102k worth of stock On the 31st of August, Lev Mizikovsky bought around 97k shares on-market at roughly AU$1.05 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Lev has been a buyer over the last 12 months, purchasing a net total of AU$2.1m worth in shares. Reported Earnings • Aug 31
Full year 2023 earnings released: EPS: AU$0.027 (vs AU$0.036 in FY 2022) Full year 2023 results: EPS: AU$0.027 (down from AU$0.036 in FY 2022). Revenue: AU$14.6m (up 13% from FY 2022). Net income: AU$1.66m (down 24% from FY 2022). Profit margin: 11% (down from 17% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has fallen by 38% per year, which means it is performing significantly worse than earnings. New Risk • Aug 09
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 154% Paying a dividend despite having no free cash flows. Earnings have declined by 18% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (2.1% increase in shares outstanding). Market cap is less than US$100m (AU$93.6m market cap, or US$61.3m). Valuation Update With 7 Day Price Move • Jul 04
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to AU$1.89, the stock trades at a trailing P/E ratio of 49.2x. Average trailing P/E is 23x in the Chemicals industry in Australia. Total loss to shareholders of 54% over the past three years. Annuncio • Jun 30
Advance ZincTek Announces Launch of EcoZinc Advance ZincTek announced the launch of EcoZinc, the solar-powered, non-nano zinc oxide powder for SPF-rated cosmetics and sunscreens. EcoZinc not only minimizes environmental impact, but also achieves a dramatic reduction in carbon emissions-saving over 1011g of CO2 per kilowatt of energy used compared to traditional zinc oxide production. Engineered via Advance ZincTek's ZinClear XP architecture, it ensures unmatched sustainability & uniform particle distribution in five BET ranges. Offering 23.08% more absorbance at a wavelength of 290nm than some competitors, EcoZinc merges top-tier skin protection and sustainability. EcoZinc's eco-friendly zinc oxide provides an integral solution for reef-safe cosmetics that meet the stringent regulations of regions such as Hawaii, Mexico, and Thailand. Through EcoZinc, companies can eliminate harmful synthetic chemicals from their products, significantly minimizing the impact on marine life. Advance ZincTek's recent announcement on June 21, 2023, revealed a significant Australian sunscreen manufacturer's commitment to transition to EcoZinc for all their products, indicating a marked shift in industry preference towards safer, sustainable sunscreen ingredients. Recent Insider Transactions • May 09
Non-Executive Chairman recently bought AU$362k worth of stock On the 5th of May, Lev Mizikovsky bought around 181k shares on-market at roughly AU$2.00 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Lev has been a buyer over the last 12 months, purchasing a net total of AU$985k worth in shares. Valuation Update With 7 Day Price Move • Feb 16
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to AU$2.63, the stock trades at a trailing P/E ratio of 67.4x. Average trailing P/E is 27x in the Chemicals industry in Australia. Total loss to shareholders of 59% over the past three years. Reported Earnings • Feb 07
First half 2023 earnings released: EPS: AU$0.021 (vs AU$0.018 in 1H 2022) First half 2023 results: EPS: AU$0.021 (up from AU$0.018 in 1H 2022). Revenue: AU$7.40m (up 24% from 1H 2022). Net income: AU$1.27m (up 19% from 1H 2022). Profit margin: 17% (in line with 1H 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 45 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Nov 23
Non-Executive Chairman recently bought AU$225k worth of stock On the 18th of November, Lev Mizikovsky bought around 100k shares on-market at roughly AU$2.25 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Lev has been a buyer over the last 12 months, purchasing a net total of AU$1.0m worth in shares. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Director Laurie Lefcourt was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Annuncio • Oct 17
Advance ZincTek Limited Declares Dividend for the Six Months Ended June 30, 2022, Payable on March 22, 2023 Advance ZincTek Limited declared dividend of AUD 0.06000000 per share for the six months ended June 30, 2022. Ex-Date is March 2, 2023, record date is March 3, 2023 and payment date is March 22, 2023. Annuncio • Oct 12
Advance ZincTek Limited, Annual General Meeting, Nov 16, 2022 Advance ZincTek Limited, Annual General Meeting, Nov 16, 2022, at 12:00 E. Australia Standard Time. Location: Australian Institute of Company Directors Level 9, Riverside Centre,123 Eagle St, Brisbane City Queensland Australia Agenda: To receive and consider the company's financial statements, the related Directors' Report, Directors' Declaration and Independent Audit Report for the financial year ended 30 June 2022; to consider remuneration Report; to consider re-Election of Rade Dudurovic as a Director; to consider election of Mrs Linda Barr as a Director; to consider Cancellation of 1,157 Employee Shares; and to consider other matters. Annuncio • Sep 23
Advance ZincTek Limited Announces Board Changes Advance ZincTek Limited announced that Laurie Lefcourt is retiring at the upcoming Annual General Meeting to take on more significant directorship roles. She will facilitate a smooth handover to company's new Non-executive Director Linda Barr. The Board announced that it has appointed Mrs. Linda Barr as a new Non-executive Director effective 23 September 2022 and her appointment will include Chairing the Audit Committee upon the retirement of Laurie Lefcourt at the upcoming AGM later this year. Linda brings to ANO an extensive knowledge in accounting systems and over 30 years in accounting and management roles. Growth and expansion focused director with executive experience in finance and ICT gained in Manufacturing, Engineering, Hospitality and Wholesale Distribution industries. Importantly, she has a wealth of experience in Pronto. She gained valuable skills in senior finance and executive roles reporting to an ASX 100 listed Company Board, where she focused on delivering strategic integration of acquisitions, identifying synergies, and creating value added services for Finance and ICT to support business operations. Reported Earnings • Aug 12
Full year 2022 earnings released: EPS: AU$0.036 (vs AU$0.001 in FY 2021) Full year 2022 results: EPS: AU$0.036 (up from AU$0.001 in FY 2021). Revenue: AU$14.3m (up 83% from FY 2021). Net income: AU$2.19m (up AU$2.16m from FY 2021). Profit margin: 15% (up from 0.4% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance. Annuncio • Aug 11
Advance ZincTek Limited Proposes Unfranked Final Dividend for the Year Ended June 30, 2022 Advance ZincTek Limited announced that subsequent to 30 June, it will be proposing to the Board to consider an unfranked final dividend of 9 cents per share. Recent Insider Transactions • Jun 26
Non-Executive Chairman recently bought AU$90k worth of stock On the 23rd of June, Lev Mizikovsky bought around 45k shares on-market at roughly AU$2.00 per share. In the last 3 months, they made an even bigger purchase worth AU$200k. Lev has been a buyer over the last 12 months, purchasing a net total of AU$2.0m worth in shares. Board Change • May 28
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Laurie Lefcourt was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Annuncio • Feb 28
Advance ZincTek Limited Company Will Resume Business as Normal After Flood Advance ZincTek Limited announced that the company's factory, stock and head office located in Rocklea have not been impacted by floods. The company will resume business as normal March 1, 2022. Reported Earnings • Feb 14
First half 2022 earnings: Revenues and EPS in line with analyst expectations First half 2022 results: EPS: AU$0.018 (up from AU$0.004 in 1H 2021). Revenue: AU$5.94m (up 36% from 1H 2021). Net income: AU$1.07m (up 375% from 1H 2021). Profit margin: 18% (up from 5.1% in 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance. Annuncio • Feb 11
Advance Zinctek Limited Provides Earnings Outlook for the Second Half of the Year 2022 Advance ZincTek Limited provided earnings outlook for the second half of the Financial year 2022. For the period, the company indicated sales forecasts of $8 million, greater than the total of FY21 of $6.5 million. Recent Insider Transactions • Nov 30
Non-Executive Chairman recently bought AU$92k worth of stock On the 29th of November, Lev Mizikovsky bought around 27k shares on-market at roughly AU$3.38 per share. In the last 3 months, they made an even bigger purchase worth AU$442k. Lev has been a buyer over the last 12 months, purchasing a net total of AU$1.4m worth in shares. Recent Insider Transactions • Nov 10
Non-Executive Chairman recently bought AU$442k worth of stock On the 8th of November, Lev Mizikovsky bought around 125k shares on-market at roughly AU$3.54 per share. This was the largest purchase by an insider in the last 3 months. Lev has been a buyer over the last 12 months, purchasing a net total of AU$1.0m worth in shares. Reported Earnings • Aug 22
Full year 2021 earnings released: EPS AU$0.001 (vs AU$0.09 in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: AU$15.0m (down 23% from FY 2020). Net income: AU$12.4m (up 133% from FY 2020). Profit margin: 83% (up from 27% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 53% per year, which means it is well ahead of earnings. Annuncio • Aug 21
Advance Nanotek Limited Provides Revenue Guidance for the First Half of Fiscal Year 2022 Advance NanoTek Limited provided revenue guidance for the first half of fiscal year 2022. The company is promising with sales revenue for the first half anticipated to be similar to that of FY19 first half sales. Recent Insider Transactions • Jul 22
Non-Executive Chairman recently bought AU$304k worth of stock On the 21st of July, Lev Mizikovsky bought around 85k shares on-market at roughly AU$3.56 per share. This was the largest purchase by an insider in the last 3 months. Lev has been a buyer over the last 12 months, purchasing a net total of AU$440k worth in shares. Recent Insider Transactions • Jul 07
Insider recently sold AU$417k worth of stock On the 2nd of July, Mirella Kearney sold around 73k shares on-market at roughly AU$5.73 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$490k more than they bought in the last 12 months. Annuncio • Jun 30
Advance NanoTek Limited has completed a Follow-on Equity Offering in the amount of AUD 4.727054 million. Advance NanoTek Limited has completed a Follow-on Equity Offering in the amount of AUD 4.727054 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 1,199,760
Price\Range: AUD 3.94
Transaction Features: Rights Offering Recent Insider Transactions • Jun 26
Non-Executive Chairman recently bought AU$72k worth of stock On the 23rd of June, Lev Mizikovsky bought around 20k shares on-market at roughly AU$3.60 per share. This was the largest purchase by an insider in the last 3 months. Lev has been a buyer over the last 12 months, purchasing a net total of AU$382k worth in shares. Reported Earnings • Feb 17
First half 2021 earnings released: EPS AU$0.004 (vs AU$0.057 in 1H 2020) The company reported a poor first half result with weaker earnings, revenues and profit margins. First half 2021 results: Revenue: AU$4.38m (down 62% from 1H 2020). Net income: AU$225.0k (down 93% from 1H 2020). Profit margin: 5.1% (down from 29% in 1H 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 99% per year, which means it is tracking significantly ahead of earnings growth. Is New 90 Day High Low • Feb 01
New 90-day low: AU$3.69 The company is down 5.0% from its price of AU$3.90 on 03 November 2020. The Australian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period. Is New 90 Day High Low • Nov 24
New 90-day high: AU$4.52 The company is up 29% from its price of AU$3.50 on 26 August 2020. The Australian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 2.0% over the same period. Valuation Update With 7 Day Price Move • Nov 09
Market bids up stock over the past week After last week's 15% share price gain to AU$4.43, the stock is trading at a trailing P/E ratio of 49.2x, up from the previous P/E ratio of 42.8x. This compares to an average P/E of 19x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 788%. Recent Insider Transactions Derivative • Nov 06
Key Executive exercised options to buy AU$1.6m worth of stock. On the 4th of November, Geoffrey Acton exercised options to buy 392.00k shares at a strike price of around AU$0.90, costing a total of AU$353k. This transaction amounted to 731% of their direct individual holding at the time of the trade. Since December 2019, Geoffrey's direct individual holding has decreased from 291.79k shares to 53.63k. Company insiders have collectively bought AU$1.0m more than they sold, via options and on-market transactions, in the last 12 months. Is New 90 Day High Low • Nov 03
New 90-day high: AU$3.90 The company is up 4.0% from its price of AU$3.76 on 05 August 2020. The Australian market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 9.0% over the same period. Valuation Update With 7 Day Price Move • Oct 15
Market bids up stock over the past week After last week's 23% share price gain to AU$3.60, the stock is trading at a trailing P/E ratio of 40x, up from the previous P/E ratio of 32.6x. This compares to an average P/E of 19x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 614%. Is New 90 Day High Low • Sep 30
New 90-day low: AU$3.21 The company is down 26% from its price of AU$4.31 on 02 July 2020. The Australian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.